Nabriva Therapeutics AG (NBRV) PT Raised to $20 at Morgan Stanley
Tweet
Share
E-mailGet Alerts NBRV Hot Sheet
Price: $1.42 --0%
Rating Summary:
4 Buy, 6 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 11 | Down: 18 | New: 17
Rating Summary:
4 Buy, 6 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 11 | Down: 18 | New: 17
Join SI Premium – FREE
Morgan Stanley analyst David Lebowitz raised the price target on Nabriva Therapeutics AG (NASDAQ: NBRV) to $20.00 (from $2.00) while maintaining a Equalweight rating.
You May Also Be Interested In
- HDFC Asset Management Co Ltd (HDFCAMC:IN) PT Raised to INR3,800 at Incred Research
- Synovus Financial (SNV) PT Lowered to $42 at Piper Sandler
- L'Oreal SA (OR:FP) (LRLCY) PT Raised to EUR480 at Barclays
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
